fda glp-1 compounding enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA cracks down on 'misleading'

Also, keep a close eye on your thyroid hormone levels

Enclomiphene is a selective estrogen receptor modulator (SERM) that has gained attention as a modern alternative for stimulati

Multi-application Capability: In many research protocols, a single vial of peptide contains more material than is needed for a single day

See if You Qualify The Ozempic Blood Clot Lawsuit is an active lawsuit See If You Qualify People are filing Ozempic lawsuits alleging the semaglutide drug caused a specific type of blood clot called a deep vein thrombosis (DVT)

When used together, they create a comprehensive strategy for restoring intestinal integrity and improving overall gastrointestinal function